View Older Stories View More Recent Stories

Jul 23, 2021 06:45AM Pfizer And BioNTech to Supply U.S. Government with an Additional 200 Million Doses of COVID-19 Vaccine to Help Meet Continued Need for Vaccine Supply in the U.S.
Jul 21, 2021 07:16AM BioNTech SE (BNTX) and Pfizer (PFE) Collaborate with SAR's Biovac for Vaccine Distribution in Africa
Jul 21, 2021 07:15AM Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa
Jul 21, 2021 07:15AM Pfizer and BioNTech Announce Collaboration With Biovac to Manufacture and Distribute COVID-19 Vaccine Doses Within Africa
Jul 21, 2021 07:15AM Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa
Jul 19, 2021 08:01AM BioNTech SE (BNTX) to Acquire Kite’s (GILD) Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD
Jul 19, 2021 08:00AM BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD
Jul 19, 2021 08:00AM BioNTech to Acquire Kite’s Neoantigen TCR Cell Therapy R&D Platform and Manufacturing Facility in Gaithersburg, MD
Jul 16, 2021 11:18AM U.S. FDA sets January target to decide on approval of Pfizer's COVID-19 shot
Jun 10, 2021 06:19AM Pfizer (PFE), BioNTech (BNTX) to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations
Jun 10, 2021 02:00AM Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations
Jun 10, 2021 02:00AM Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations
Jun 10, 2021 02:00AM Pfizer and BioNTech to Provide 500 Million Doses of COVID-19 Vaccine to U.S. Government for Donation to Poorest Nations
May 28, 2021 03:47PM Pfizer (PFE), BioNTech (BNTX) Receive First Authorization in European Union for COVID-19 Vaccine in Adolescents
May 28, 2021 03:45PM Pfizer and BioNTech Receive First Authorization in European Union for COVID-19 Vaccine in Adolescents
May 28, 2021 03:45PM Pfizer and BioNTech Receive First Authorization in European Union for COVID-19 Vaccine in Adolescents
May 24, 2021 06:45AM Pfizer (PFE) Initiates Study Exploring Coadministration of Its 20-valent Pneumococcal Conjugate Vaccine Candidate Along With a Third Dose of the Pfizer-BioNTech (BNTX) COVID-19 Vaccine in Older Adults
May 24, 2021 06:45AM Pfizer Initiates Study Exploring Coadministration of Its 20-valent Pneumococcal Conjugate Vaccine Candidate Along With a Third Dose of the Pfizer-BioNTech COVID-19 Vaccine in Older Adults
May 20, 2021 06:16AM Pfizer (PFE), BioNTech SE (BNTX) to Supply EU with 1.8 Billion Additional Doses of COVID-19 Vaccine
May 20, 2021 06:14AM Pfizer (PFE), BioNTech (BNTX) Sign Agreement for Additional Supply to Turkey of 60 Million Doses of their COVID-19 Vaccine
May 20, 2021 06:00AM Pfizer and BioNTech Sign Agreement for Additional Supply to Turkey of 60 Million Doses of their COVID-19 Vaccine
May 20, 2021 06:00AM Pfizer and BioNTech Sign Agreement for Additional Supply to Turkey of 60 Million Doses of their COVID-19 Vaccine
May 20, 2021 05:00AM Pfizer and BioNTech to Supply the European Union with up to 1.8 Billion Additional Doses of COMIRNATY®
May 20, 2021 05:00AM Pfizer and BioNTech to Supply the European Union With up to 1.8 Billion Additional Doses of COMIRNATY®
May 20, 2021 05:00AM Pfizer and BioNTech to Supply the European Union with up to 1.8 Billion Additional Doses of COMIRNATY®
May 11, 2021 02:30AM Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
May 11, 2021 02:30AM Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
May 10, 2021 09:02PM Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents
May 7, 2021 06:48AM Pfizer (PFE) and BioNTech (BNTX) Initiate Rolling Submission of BLA for U.S. FDA Approval of Their COVID-19 Vaccine
May 7, 2021 06:45AM Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of their COVID-19 Vaccine
May 7, 2021 06:45AM Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of Their COVID-19 Vaccine
May 7, 2021 06:45AM Pfizer and BioNTech Initiate Rolling Submission of Biologics License Application for U.S. FDA Approval of their COVID-19 Vaccine
May 6, 2021 06:30AM Pfizer (PFE) and BioNTech (BNTX) to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games
May 6, 2021 06:30AM Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games
May 6, 2021 06:30AM Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games
May 6, 2021 06:30AM Pfizer and BioNTech to Provide COVID-19 Vaccine Doses for Olympic Athletes at the 2020 Tokyo Games
Apr 30, 2021 07:03AM Pfizer (PFE), BioNTech (BNTX) Submit Request to Expand Conditional Marketing Authorization of Vaccine in EU to Adolescents
Apr 30, 2021 07:00AM Pfizer and BioNTech Submit Request to Expand Conditional Marketing Authorization of COMIRNATY® in the EU to Adolescents
Apr 30, 2021 07:00AM Pfizer and BioNTech Submit Request to Expand Conditional Marketing Authorization of COMIRNATY® in the EU to Adolescents
Apr 19, 2021 06:16AM Pfizer (PFE) and BioNTech (BNTX) to Supply EU with 100 Million Additional Doses of COVID-19 Vaccine
Apr 19, 2021 04:00AM Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
Apr 19, 2021 04:00AM Pfizer and BioNTech to Supply the European Union with 100 Million Additional Doses of COMIRNATY®
Apr 1, 2021 06:45AM Pfizer (PFE) and BioNTech (BNTX) Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study
Apr 1, 2021 06:45AM Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study
Apr 1, 2021 06:45AM Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study
Apr 1, 2021 06:45AM Pfizer and BioNTech Confirm High Efficacy and No Serious Safety Concerns Through Up to Six Months Following Second Dose in Updated Topline Analysis of Landmark COVID-19 Vaccine Study
Mar 31, 2021 06:45AM Pfizer (PFE), BioNTech (BNTX) COVID-19 Vaccine 100% Effective in Adolescents 12 to 15 Years of Age, Trial Shows
Mar 31, 2021 06:45AM Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents
Mar 31, 2021 06:45AM Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents
Mar 31, 2021 06:45AM Pfizer-BioNTech Announce Positive Topline Results of Pivotal COVID-19 Vaccine Study in Adolescents
View More Recent Stories View Older Stories